Matches in Wikidata for { <http://www.wikidata.org/entity/Q50588834> ?p ?o ?g. }
- Q50588834 description "2015 nî lūn-bûn" @default.
- Q50588834 description "2015年の論文" @default.
- Q50588834 description "2015年学术文章" @default.
- Q50588834 description "2015年学术文章" @default.
- Q50588834 description "2015年学术文章" @default.
- Q50588834 description "2015年学术文章" @default.
- Q50588834 description "2015年学术文章" @default.
- Q50588834 description "2015年学术文章" @default.
- Q50588834 description "2015年學術文章" @default.
- Q50588834 description "2015年學術文章" @default.
- Q50588834 description "2015年學術文章" @default.
- Q50588834 description "2015年學術文章" @default.
- Q50588834 description "2015年學術文章" @default.
- Q50588834 description "2015년 논문" @default.
- Q50588834 description "article científic" @default.
- Q50588834 description "article scientific" @default.
- Q50588834 description "article scientifique" @default.
- Q50588834 description "articol științific" @default.
- Q50588834 description "articolo scientifico" @default.
- Q50588834 description "artigo científico" @default.
- Q50588834 description "artigo científico" @default.
- Q50588834 description "artigo científico" @default.
- Q50588834 description "artikel ilmiah" @default.
- Q50588834 description "artikull shkencor" @default.
- Q50588834 description "artikulong pang-agham" @default.
- Q50588834 description "artykuł naukowy" @default.
- Q50588834 description "artículo científico publicado en 2015" @default.
- Q50588834 description "artículu científicu" @default.
- Q50588834 description "bilimsel makale" @default.
- Q50588834 description "bài báo khoa học" @default.
- Q50588834 description "naučni članak" @default.
- Q50588834 description "scienca artikolo" @default.
- Q50588834 description "scientific article published on 29 April 2015" @default.
- Q50588834 description "scientific article published on 29 April 2015" @default.
- Q50588834 description "scientific article published on 29 April 2015" @default.
- Q50588834 description "teaduslik artikkel" @default.
- Q50588834 description "tieteellinen artikkeli" @default.
- Q50588834 description "tudományos cikk" @default.
- Q50588834 description "vedecký článok" @default.
- Q50588834 description "vetenskaplig artikel" @default.
- Q50588834 description "videnskabelig artikel" @default.
- Q50588834 description "vitenskapelig artikkel" @default.
- Q50588834 description "vitskapeleg artikkel" @default.
- Q50588834 description "vědecký článek" @default.
- Q50588834 description "wetenschappelijk artikel" @default.
- Q50588834 description "wissenschaftlicher Artikel" @default.
- Q50588834 description "επιστημονικό άρθρο" @default.
- Q50588834 description "мақолаи илмӣ" @default.
- Q50588834 description "наукова стаття, опублікована у квітні 2015" @default.
- Q50588834 description "научна статия" @default.
- Q50588834 description "научная статья" @default.
- Q50588834 description "научни чланак" @default.
- Q50588834 description "научни чланак" @default.
- Q50588834 description "מאמר מדעי" @default.
- Q50588834 description "مقالة علمية نشرت في 29 أبريل 2015" @default.
- Q50588834 description "২৯ এপ্রিল ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q50588834 description "บทความทางวิทยาศาสตร์" @default.
- Q50588834 description "სამეცნიერო სტატია" @default.
- Q50588834 name "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 name "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 type Item @default.
- Q50588834 label "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 label "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 prefLabel "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 prefLabel "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 P1433 Q50588834-4618D200-233E-479D-9FA7-2A7B8DBCE6F8 @default.
- Q50588834 P1476 Q50588834-279024B4-79E6-4CA7-BB4C-ADDC5F4F129A @default.
- Q50588834 P2093 Q50588834-49F70553-3CD9-46F8-9558-9E81A22F5552 @default.
- Q50588834 P2093 Q50588834-67322678-BFE3-4E25-8105-C50B6ACEA263 @default.
- Q50588834 P2093 Q50588834-92182331-EB90-4EE3-BEC0-32A620AF00B7 @default.
- Q50588834 P2093 Q50588834-DAA9EC97-851A-4797-8FF4-88286A6D9C3A @default.
- Q50588834 P304 Q50588834-436C0994-A313-456A-BF14-A9DB25339B27 @default.
- Q50588834 P31 Q50588834-B4648ED7-99B3-469C-860A-42D322CC8C21 @default.
- Q50588834 P356 Q50588834-E61F31F7-2DB0-4704-8A9B-53B0C783408D @default.
- Q50588834 P433 Q50588834-E9B68DCF-6CAF-47C6-A14D-DE0796100B3E @default.
- Q50588834 P478 Q50588834-23FF01C3-EBC6-4EF3-86F0-16A117506800 @default.
- Q50588834 P577 Q50588834-4EF58BC0-2B75-4348-8252-76F922D58DB8 @default.
- Q50588834 P5875 Q50588834-E6139E9B-7638-4B4B-996D-D3A12722FEDD @default.
- Q50588834 P698 Q50588834-227EDC76-F671-46AE-AF2C-566B201877BE @default.
- Q50588834 P8608 Q50588834-9A3294A0-E870-4D63-9CAF-B9A6E1F77AE9 @default.
- Q50588834 P921 Q50588834-1F849C55-87AB-44D6-8FAF-D04DF4338287 @default.
- Q50588834 P921 Q50588834-20CC524D-ED62-44AF-A686-247D1A3C8E01 @default.
- Q50588834 P921 Q50588834-213A3D57-BED9-4D50-8529-7453B5610513 @default.
- Q50588834 P921 Q50588834-7E3A03EE-833D-4C33-BE29-9C8AC8F5BA7C @default.
- Q50588834 P921 Q50588834-F0125EC4-FE7E-47B0-BE98-86E52D82646E @default.
- Q50588834 P356 J.EJVS.2015.02.022 @default.
- Q50588834 P698 25933476 @default.
- Q50588834 P1433 Q15757064 @default.
- Q50588834 P1476 "Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Poi" @default.
- Q50588834 P2093 "A Handa" @default.
- Q50588834 P2093 "I Milosevic" @default.
- Q50588834 P2093 "K V Hurst" @default.
- Q50588834 P2093 "R Lee" @default.
- Q50588834 P304 "126-127" @default.
- Q50588834 P31 Q13442814 @default.
- Q50588834 P356 "10.1016/J.EJVS.2015.02.022" @default.
- Q50588834 P433 "1" @default.
- Q50588834 P478 "50" @default.
- Q50588834 P577 "2015-04-29T00:00:00Z" @default.
- Q50588834 P5875 "275673939" @default.